In person As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies…
10th RSC-BMCS Fragment-based Drug Discovery Meeting
In person ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September. The meeting brings together scientists from across academia, biotechnology, and the pharmaceutical industry to discuss advances and impactful applications of fragment-based drug discovery. ZoBio will be represented by Johan Veerman, Head of Chemistry, who will also present a…
EUROMAR 2026
In person As in the previous years ZoBio attended the European Conference on Magnetic Resonance, which took place in Göteborg, Sweden. Stephan Theisgen presented a poster demonstrating how strategically integrating solution-state NMR into commercial drug discovery programs provides critical structural insights across the early preclinical pipeline. The poster highlighted how NMR complements biochemical assays, biophysical…
ZoBio Launches Comprehensive DEL Hit Discovery Service for Challenging Targets
LEIDEN, NL
ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its comprehensive…